Aa
Home
Entertainment
Sports
Politics
Fashion
Business
Health
Education
Financial
Home
>
fashion

Correction: Senkyunolide A ameliorates cholestatic liver fibrosis by controlling CLCC1-mediated endoplasmic reticulum Ca 2+ release

Dr. Robert Lee
Published on 2026-11-09 00:00:00
News Site
Correction: Senkyunolide A ameliorates cholestatic liver fibrosis by controlling CLCC1-mediated endoplasmic reticulum Ca 2+ release

Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-025-01615-6, published online 15 July 2025

The authors wish to report errors in the published version of this article. It was identified that the images in Figures 1f, 4d, 8b and 8g showed inadvertent layout during figure assembly. The incorrect images have now been replaced with the correct images from the same experimental set. The corrected full figures and its corresponding figure legends are provided below.

The authors confirm that this correction does not affect the scientific results, interpretations, or conclusions of the study. The authors sincerely apologize for this error and any inconvenience caused.

The original article has been corrected.

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Li, Yj., Guo, My., Qin, Wq. et al. Correction: Senkyunolide A ameliorates cholestatic liver fibrosis by controlling CLCC1-mediated endoplasmic reticulum Ca2+ release. Acta Pharmacol Sin (2026). https://doi.org/10.1038/s41401-026-01963-x

Published:

Version of record:

DOI: https://doi.org/10.1038/s41401-026-01963-x

Recommend

  • Copyright © Pubnews.online
  • Privacy Agreement
  • About us
English